Progressive Care Announces Integration With Salesforce
09 Novembre 2022 - 1:13PM
InvestorsHub NewsWire
Miami, FL -- November 9, 2022 -- InvestorsHub NewsWire
-- Progressive Care Inc. (OTCQB:
RXMD) (“Progressive Care” or the “Company”), a personalized
healthcare services and technology company, is pleased to announce
it has chosen the Salesforce Customer 360 Cloud to support
initiatives in key business areas including retail, 340B, long-term
care, and third-party administration (TPA) services.
Open web
version
“We’re really excited to empower our sales, service, and
marketing teams with technology that not only simplifies the
prospecting process, but also provides our managers with strong
tools to target new leads,” said Alan Jay Weisberg, CEO at
Progressive Care Inc. “Salesforce Cloud will help our teams
leverage the power of digital media to target specific audiences,
reduce costs, and offer a clear view of each prospect’s current
status in real-time.”
The company has started working with technology consultancy firm
OffPrem, to begin the integration process of Salesforce into its
technology ecosystem. This process will include data integration,
platform configuration, and ongoing training. Salesforce is the
leading customer relationship management system, ranked #1 for CRM
Applications based on IDC 2021 Revenue Market Share Worldwide and
servicing more than 150,000 businesses worldwide.
For more information about Progressive Care, please visit the
company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
PharmCoRx
https://www.pharmcorx.com/
ClearMetrX
https://www.clearmetrx.com/
About Progressive Care:
Progressive Care Inc. (OTCQB:
RXMD), through its subsidiaries, is a Florida health services
organization and provider of Third-Party Administration (TPA), data
management, COVID-19 related diagnostics and vaccinations, 340B
contracted pharmacy services, prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Disclosure Regarding Forward-Looking Statements
Forward-Looking Statements contained herein that are not based
upon current or historical fact are forward-looking in nature and
constitute forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934. Such forward-looking statements reflect the
Company’s expectations about its future operating results,
performance, and opportunities that involve substantial risks and
uncertainties. When used herein, the words “anticipate,” “believe,”
“estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and
similar expressions, as they relate to Progressive Care Inc., its
subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company’s actual results, performance, prospects,
and opportunities to differ materially from those expressed in, or
implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Progressive Care (QB) (USOTC:RXMD)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Progressive Care (QB) (USOTC:RXMD)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024